Rapid pulmonary fibrosis induced by acute lung injury via a lipopolysaccharide three-hit regimen

Abstract

Based on the common characteristic of severe acute respiratory syndrome (SARS) and highly pathogenic avian influenza and the mechanism of inflammation and fibrosis, it is speculated that there should exist a fundamental pathological rule that severe acute lung injury (ALI)-induced rapid pulmonary fibrosis is caused by various etiological factors, such as SARS coronavirus, H5N1-virus, or other unknown factors, and also by lipopolysaccharide (LPS), the most common etiological factor. The investigation employed intratracheally, and intraperitoneally and intratracheally applied LPS three-hit regimen, compared with bleomycin-induced chronic pulmonary fibrosis. Inflammatory damage and fibrosis were evaluated, and the molecular mechanism was analyzed according to Th1/Th2 balance, Sma- and MAD-related proteins (Smads) and signal transducer and activator of transcriptions (STATs) expression. The results suggested that rapid pulmonary fibrosis could be induced by ALI via LPS three-hits. The period from 3—7 days in the LPS group was the first rapid pulmonary fibrosis stage, whereas the second fast fibrosis stage occurred on days 14—21. Th2 cell polarization, Smad4 and Smad7 should be the crucial molecular mechanism of ALI-induced rapid fibrosis. The investigation was not only performed to establish a new rapid pulmonary fibrosis model, but also to provide the elicitation for mechanism of ALI changed into the rapid pulmonary fibrosis.

Keywords

Acute lung injury lipopolysaccharide pulmonary fibrosis signal transducer and activator of transcription Sma- and MAD-related proteins

References

World Health Organization. The World Health Report 2007 - A safer future: global public health security in the 21st century. Message from the Director-General. Geneva WHO, 2007; vi.

Wong GW , Leung TF Bird flu: lessons from SARS. Paediatr Respir Rev 2007; 8: 171-176.

Writing Committee of the Second World Health Organization Consultation. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008 ; 358: 261-273.

Joynt GM , Antonio GE , Lam P. et al. Late-stage adult respiratory distress syndrome caused by severe acute respiratory syndrome: abnormal findings at thin-section CT. Radiology 2004; 230: 339-346.

Franks TJ , Chong PY , Chui P. et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol 2003; 34: 743-748.

Lian T. , Yi-min Z. , Xiao L. et al. A case report of the human avian influenza pneumonia in China. J Chinese Phys 2006; 8: 293-296.

Ng WF , To KF , Lam WW et al. The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1 - a review. Hum Pathol 2006; 37: 381-390.

Lantz RC , Birch K. , Hinton DE et al. Morphometric changes of the lung induced by inhaled bacterial endotoxin. Exp Mol Pathol 1985; 43: 305-320.

Downey GP , Granton JT Mechanisms of acute lung injury. Curr Opin Pulmon Med 1997; 3: 234-241.

10.

Phan SH , Fantone JC Inhibition of bleomycin-induced pulmonary fibrosis by lipopolysaccharide . Lab Invest 1984; 50: 587-591.

11.

Luo F. , Hou W. , Yang ZQ et al. Intratracheal inoculation of severe acute respiratory syndrome coronavirus in monkeys Macaca rhesus. Acta Virol 2007; 51: 171-177.

12.

Glass WG , Subbarao K. , Murphy B. et al. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol 2004; 173: 4030-4039.

13.

Zhang X. , Alekseev K. , Jung K. et al. Cytokine responses in porcine respiratory coronavirus-infected pigs treated with corticosteroids as a model for severe acute respiratory syndrome. J Virol 2008; 82: 4420-4428.

14.

Corbel M. , Theret N. , Caulet-Maugendre S. et al. Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activity. Inflamm Res 2001; 50: 129-135.

15.

Hagiwara S. , Iwasaka H. , Matsumoto S. et al. Association between heat stress protein 70 induction and decreased pulmonary fibrosis in an animal model of acute lung injury. Lung 2007; 185: 287-293.

16.

Hagiwara S. , Iwasaka H. , Matsumoto S. et al. Introduction of antisense oligonucleotides to heat shock protein 47 prevents pulmonary fibrosis in lipopolysaccharide-induced pneumopathy of the rat. Eur J Pharmacol 2007; 564: 174-180.

17.

Ademson IYR , Bowden DH The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 1974 ; 77: 185.

18.

Nicholls J. , Dong XP , Jiang G. et al. SARS: clinical virology and pathogenesis . Respirology 2003; 8: s6-s8.

19.

Ooi GC , Khong PL , Mûller NL et al. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. Radiology 2004; 230: 836-844.

20.

Qureshi NR , Hien TT , Farrar J. et al. The radiologic manifestations of H5N1 avian influenza. J Thorac Imaging 2006; 21: 259-264.

21.

Wallace WA , Howie SE , Krajewski AS et al. The immunological architecture of B-lymphocyte aggregates in cryptogenic fibrosing alveolitis. J Pathol 1996; 178: 323-329.

22.

Szretter KJ , Gangappa S. , Lu X. et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007; 81: 2736-2744.

23.

To KF , Chan PK , Chan KF et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 2001; 63: 242-246.

24.

Wong CK , Law CW , Wu AK et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004 ; 136: 95-103.

25.

Baas T. , Taubenberger JK , Chong PY et al. SARS-CoV virus-host interaction and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues. J Interferon Cytokine Res 2006; 26: 309-317.

26.

Huang J. L, Huang J. , Duan ZH et al. Th2 predominance and CD8+ memory T cell depletion in patients with severe acute respiratory syndrome. Microbes Infect 2005; 7: 427-436.

27.

Gauldie J. , Kolb M. , Ask K. et al. Smad3 signaling involved in pulmonary fibrosis and emphysema . Proc Am Thorac Soc 2006; 3: 696-702.

28.

Wei S. , Jin-nong Z. Th1/Th2 polarization in emphysema and pulmonary fibrosis. Int J Respir 2007; 27: 551-553.

29.

Ri-quan L. , Xiao-dong F. , Ying-ying GU et al. Pathological changes of lungs in patients with severity acute respiratory syndrom. Chinese J Pathol 2004 ; 33: 354-357.

30.

Zhang Y. , Li J. , Zhan Y. et al. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun 2004; 72: 4410-4415.

31.

Huang KJ , Su IJ , Theron M. et al. An interferon-gamma-related cytokine storm in SARS patients . J Med Virol 2005; 75: 185-194.

32.

Verrescchia F. , Mauviel A. Transforming growth factor-beta and fibrosis . World J Gastroenterol 2007; 13: 3056-3062.

33.

Zhao X. , Nicholls JM , Chen YG Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling . J Biol Chem 2008; 283: 3272-3280.

34.

Ulloa L. , Doody J. , Massague J. Inhibition of transforming growth factor-beta/SMAD signaling by the interferon-gama/ STAT pathway. Nature 1999 ; 397: 710-713.

35.

Yamamoto T. , Matsuda T. , Muraguchi A. et al. Cross-talk between IL-6 and TGF-beta signaling in hepatoma cells. FEBS Lett 2001 ; 492: 247-253.

36.

Long J. , Matsuura L. , He D. et al. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT. Proc Natl Acad Sci USA 2003; 100: 9791-9796.

37.

Cocolakis E. , Dai M. , Drevet L. et al. Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation. J Biol Chem 2008; 283: 1293-1307.

38.

Iwamoto T. , Oshima K. , Seng T. et al. STAT and SMAD signaling in cancer. Histol Histopathol 2002; 17: 887-895.

39.

Dos Santos CC Advances in mechanisms of repair and remodelling in acute lung injury. Intensive Care Med 2008 ; 34: 619-630.

40.

Chambers RC Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention ? Br J Pharmacol 2008; 153: s367-s378.

41.

Budinger GR , Chandel NS , Donnelly HK et al. Active transforming growth factor-beta1 activates the procollagen I promoter in patients with acute lung injury. Intensive Care Med 2005 ; 31: 121-128.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.12 MB

0.00 MB